As a result, the expressions of occludin and claudin1 were remarkably decreased in model group, and recovered after SGD treatment, suggesting that the prescription could protect the mucosal barrier in PCOS rats. The gene discussed is CLDN7; the disease is polycystic ovary syndrome.